Adhami, H. (1979). Influence of 6-mercaptopurine on the prenatal development of the rat cortex. Z. Mikrosk-Anat. Forsch. 93:21-32.
2.
Allan, P.W., Schnebli, H.P. and Bennett, L.L. (1966). Conversion of 6-mercaptopurine and 6-mercaptopurine ribonucleoside to 6-methyl-mercaptopurine ribonucleotide in human epidermoid carcinoma No. 2 cells in culture. Biochim. Biophys. Acta114: 647-650.
3.
Alleva, F.R., Haberman, B.H., Slaughter, L.J. and Balazs, T. (1981). Muscle degeneration in rats after postnatal treatment with 6-mercaptopurine. Drug Chem. Toxicol. 4:133-136.
4.
Alleva, F.R., Slaughter, L.J., Abraham, A.A. and Balazs, T. (1984). Further studies on 6-mercaptopurine-induced muscle atrophy in rats, mice and hamsters treated as neonates. Pediatr. Pharmacol. 4:39-48.
5.
Bartolome, J., Huguenard, J. and Slotkin, T.A. (1980). Role of ornithine decarboxylase in cardiac growth and hypertrophy. Science210:793-794.
6.
Drake, S., Burns, R.L. and Nelson, T.A. (1982). Metabolism and mechanisms of action of 9-(tetrahydro-2-furyl)-6-mercaptopurine in chinese hamster ovary cells. Chem.-Biol. Interact. 41:105-115.
7.
Elion, G.B. (1967). Biochemistry and pharmacology of purine analogues . Fed. Proc. 26:898-904.
8.
Elion, G.B., Singer, S. and Hitchings, G.H. (1954). Microbiological effects of 6-mercaptopurine. Ann. N. Y. Acad. Sci. 60:200-206.
9.
Friedman, L., Scalera, J., Keys, J.E., Peters, E.L., Gaines, D.W., Stone, C.L., Kasza, L. and Balazs, T. (1982). Some biochemical and histological effects of 2-chloroethanol in rats. J. Amer. Coll. Toxicol. 3:37-55.
10.
Friedman, L. and Yin, L. (1973). Influence of hypophysectomy on the biochemical effects and metabolism of aflatoxin B1 in rats. J. Natl. Cancer Inst. 51:479-487.
11.
Hakala, M.T. and Nichol, C.A. (1964). Prevention of the growth-inhibiting effect of 6-mercaptopurine by 4-amino-imidazole-5-carboxamide. Biochim. Biophys. Acta80: 665-668.
12.
Jaweed, M.M., Butler, T.M., Alleva, F.R., Balazs, T. and Bianchi, C.P. (1983). Changes in high energy phosphates in 6-mercaptopurine-treated rat muscles. Toxicol. Lett. 18:87.
13.
Kawahata, R.L., Chuang, L.F., Holmberg, C.A., Osburn, B.I. and Chuang, R.Y. (1983). Inhibition of human lymphoma DNA-dependent RNA polymerase activity by 6-mercaptopurine ribonucleoside triphosphate. Cancer Res. 43:3655-3659.
14.
Kawahata, R.L., Holmberg, C.A., Osburn, B.I., Chuang, L.F. and Chuang, R.Y. (1980). Effect of 6-mercaptopurine ribonucleotides on DNA-dependent RNA polymerase activity. Mol. Pharmacol. 18:503-506.
15.
Lau, C. and Slotkin, T.A. (1979). Regulation of rat heart ornithine decarboxylase: Changes in affinity for ornithine evoked by neuronal, hormonal and ontogenetic stimuli. Mol. Pharmacol. 16:504-512.
16.
Nelson, J.A., Carpenter, J.W., Rose, L.M. and Adamson, D.J. (1975). Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine. Cancer Res. 35:2872-2878.
17.
Pegg, A.E. and Mccann, P.P. (1982). Polyamine metabolism and function. Am. J. Physiol. 243:C212-221.
18.
Philips, F.S., Sternberg, S.S., Hamilton, L. and Clarke, D.A. (1954). The toxic effects of 6-mercaptopurine and related compounds. Ann. N.Y. Acad. Sci. 60:283-296.
19.
Russell, D.H. (1980). Ornithine decarboxylase as a biological and pharmacological tool. Pharmacology20:117-129.
20.
Russell, D.H. and Durie, B.G.M. (1978). Polyamines as biochemical markers of normal and malignant growth. In: Progress in Cancer Research and Therapy . New York: Raven Press.
21.
Russell, D.H. and Snyder, S.H. (1968). Amine synthesis in rapidly growing tissues: Ornithine decarboxylase activity in regenerating rat liver, chick embryo and various tissues. Proc. Natl. Acad. Sci. USA60:1420-1427.
22.
Sadah, M., Stern, L.Z., Czyzewski, K., Finley, P.R. and Russell, D.H. (1984). Alterations in creatine kinase, ornithine decarboxylase, and transglutaminase during muscle regeneration. Life Sci . 34:483-488.
23.
Sas User'S Guide: STATISTICS. Cary, North Carolina: SAS Institute Inc., pp. 217-222.
24.
Schneider, W.C. (1957). Determination of nucleic acids in tissues by pentose analysis. In: Methods in Enzymology, Vol. 3 (S.P. Colowick and N.O. Kaplan, eds). New York: Academic Press, pp. 680-684.
25.
Shapkina, A.V. (1981). Changes in cells in the terminal portion of the pancreas following resection and administration of immunosuppressants. Arkh. Anat. Gistol. Embriol. 80:77-82.
26.
Skipper, H.E. (1954). On the mechanism of action of 6-mercaptopurine . Ann. N.Y. Acad. Sci. 60:315-321.
27.
Slotkin, T.A., Seidler, F.J., Trepanier, P.A., Whitmore, W.L., Lerea, L., Barnes, G.A., Weigel, S.G. and Bartolome, J. (1982). Ornithine decarboxylase and polyamines in tissues of the neonatal rat: Effects of alpha-difluromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase. J. Pharmacol. Exp. Ther . 222:741-745.
28.
Thiersch, J.B. (1954). The effect of 6-mercaptopurine on the rat fetus and on reproduction of the rat. Ann. N.Y. Acad. Sci. 60:220-227.
29.
Tidd, D.M. and Paterson, A.R.P. (1974). A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res. 34:738-746.
30.
Tidd, D.M. and Paterson, A.R.P. (1972). Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine . Cancer Res. 32:317-322.
31.
Uvelius, B., Persson, L. and Mattiasson ( 1984). Smooth muscle cell hypertrophy and hyperplasia in the rat detrusor after short-time infravesical outflow obstruction. J. Urol. 131:173-176.
32.
Zittoun, R., Bouchard, M., Facquet-Denis, J., Diaz-Mayo, C., Percie-Du-Sert, M. and Bousser, J. (1975). In vitro study of sensitivity of leukemic cells to cytotoxic drugs. Nouve Presse Med. 4:401-404.
